The Pacific Coast Part 1: AI and Drug Discovery Intersect in the Pacific Northwest
The Pacific Northwest is rapidly advancing as a center for AI-driven drug discovery through coordinated federal initiatives, startup investment, and expanding research infrastructure across Seattle, Portland, and Vancouver.
The article highlights how organizations including Pacific Northwest National Laboratory, the University of Washington’s Institute for Protein Design, Fred Hutchinson Cancer Center, and multiple regional startups are applying artificial intelligence to accelerate biological research and therapeutic development. “PNNL’s leadership in the Department of Energy’s Genesis Mission reinforces the state’s reputation for transforming complex science into real-world impact, elevating the region’s visibility in life sciences and beyond,” said Life Science Washington CEO Marc Cummings.
The region’s growing concentration of AI expertise, biotechnology investment, and research collaboration positions the Pacific Northwest as an increasingly influential center for next-generation life sciences innovation.